To include your compound in the COVID-19 Resource Center, submit it here.

ODM-201: Phase III started

Orion and Bayer began the double-blind, placebo-controlled, international Phase III ARAMIS trial to

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE